Johnson & JohnsonvsPennant

JNJ and PNTG stock compared: price, dividend, valuation and results, from SEC filings.

PNTG

The Pennant Group, Inc.

$34.09

Value $1.2B

-1.89%
PNTG's page

Johnson & Johnson (JNJ) has a market value of $644B and Pennant (PNTG) $1.2B. Over the last year, with dividends, JNJ moved +39.7% and PNTG +41.0%. The P/E is 40.0 for JNJ and 32.9 for PNTG. Dividend yield: JNJ 1.98%, PNTG none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    JNJ$644B

    PNTG$1.2B

    JNJ is 545 times PNTG

  • Revenue, 12 months

    JNJ$99.3B

    PNTG$1.2B

    JNJ is 85 times PNTG

  • Net income, 12 months

    JNJ$16.1B

    PNTG$36M

    JNJ is 449 times PNTG

  • Operating margin

    JNJ–

    PNTG5.8%

  • ROIC

    JNJ12.4%

    PNTG9.4%

    3.0 points apart

  • P/E

    JNJ40.0

    PNTG32.9

    JNJ is 1.2 times PNTG

  • Dividend yield

    JNJ2.0%

    PNTG0.0%

    2.0 points apart

  • 5-year return

    JNJ+92.0%

    PNTG+47.1%

    44.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

JNJ+92.0%

PNTG+47.1%

5010015020020222023202420252026
Returns by period
PeriodJNJWith dividendsPNTGWith dividends
1 year since November 17, 2025+39.7%Price +36.6%+41.0%Price +41.0%
3 years since November 17, 2023+98.2%+25.6% a yearPrice +82.1%+172.3%+39.6% a yearPrice +172.3%
5 years since November 17, 2021+92.0%+13.9% a yearPrice +67.0%+47.1%+8.0% a yearPrice +47.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

JNJJohnson & JohnsonPNTGPennant

Valuation

JNJPNTG
Valuation
Price$267.14$34.09
Market value$644B$1.2B
Enterprise value (EV)$671B$1.4B
P/E40.032.9
P/E, 5-year median21.935.7
P/B7.92.8
EV/EBIT37.820.0
Free cash flow yield3.2%2.9%

Results and growth

JNJPNTG
Results and growth
Revenue, 12 months$99.3B$1.2B
Net income, 12 months$16.1B$36M
Free cash flow, 12 months$20.6B$34M
Earnings per share, 12 months$6.59$1.00
Revenue growth, year on year6.1%36.3%
Revenue growth a year, past+2.7%over 5 years+19.4%over 5 years
EPS growth a year, past+14.9%over 5 years+10.1%over 5 years

Margins and returns on capital

JNJPNTG
Margins and returns on capital
Gross margin67.6%18.3%
Operating margin–5.8%
Net margin16.2%3.1%
ROIC12.4%9.4%
ROE19.7%9.3%

Balance sheet

JNJPNTG
Balance sheet
Cash$17.2B$18M
Total debt$44.7B$489M
Net debt / EBITDA1.12.4
Interest cover18.0×5.2×

Dividends and buybacks

JNJPNTG
Dividends and buybacks
Dividend yield2.0%–
Dividend per share, 12 months$5.28–
Dividend growth a year, past+5.3%over 5 years–
Buyback yield0.9%–
Shareholder yield2.9%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: JNJ or PNTG

Didn't find what you were looking for?

Ask us
Which is bigger, Johnson & Johnson or Pennant?

By market value, Johnson & Johnson ($644B) is about 544.8 times Pennant ($1.2B), at today's prices.

How did JNJ and PNTG stock do over the last 5 years?

Since November 17, 2021, JNJ's price moved +67.0% and PNTG's +47.1%. With dividends: JNJ +92.0% (+13.9% a year), PNTG +47.1% (+8.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, JNJ or PNTG?

The dividend yield at today's price is 1.98% for Johnson & Johnson and none for Pennant. Over the last twelve months they paid $5.28 and – per share.

What is the P/E of JNJ and PNTG?

At today's price, the P/E is 40.0 for JNJ and 32.9 for PNTG. The median of the last five years was 21.9 and 35.7, which shows where each stands against its own past.

Which has the higher profit margins, Johnson & Johnson or Pennant?

Over the last twelve months, the net margin was 16.2% for Johnson & Johnson and 3.1% for Pennant, and the operating margin – and 5.8%. Revenue was $99.3B and $1.2B.

Which is the better investment, Johnson & Johnson or Pennant?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.